Zscaler (ZS) Q3 FY2026 — Beat on Revenue, Guidance Shock, 32% Drop

What Happened

ZS reported Q3 FY2026 on May 26 and proceeded to drop ~32% in a single session — one of the worst earnings reactions in the stock’s history. The business beat on revenue and EPS. The market punished the guidance.

• Revenue: $850.5M (+25% YoY) — beat estimates
• Adjusted EPS: beat estimates
• ARR: $3.525B (+25% YoY)
• Free Cash Flow: $136M
• Stock reaction: -32% on the day

Why the Market Cratered It

The issue wasn’t the quarter. It was the guide.

ARR growth guidance came in at 16–17% — a significant step-down from the 25% growth they just printed. Management flagged losing a couple of key salespeople as the driver behind the conservative stance. That’s a red flag on execution, not a macro excuse.

Q4 revenue guidance of $875–$878M essentially met analyst expectations (~$878.6M) but didn’t exceed them. For a premium-multiple growth stock, that reads as deceleration, not continuation.

Context on how far it’s already fallen:

• Down ~40% YTD heading into earnings
• Down ~61% from its 52-week high of $336.99
• Now trading at ~$136 after the post-earnings bounce (article noted +4.85% recovery day)

The Thesis — What Still Holds

The underlying business case for ZS hasn’t changed. Zero trust network access becomes more necessary, not less, as AI scales. Every enterprise AI deployment creates new attack surface. ZS processes nearly 1 trillion AI/ML transactions annually across ~9,000 organizations — they’re already embedded before most companies know they need them.

AMZN and NOW make money when AI makes them more efficient. ZS makes money because AI makes the world less secure. Different vector, same macro driver.

The New Valuation Setup

The multiple compression changes the picture materially:

• Current price: ~$136
• 52-week high: $336.99
• Forward P/E: ~27x (was 45x+ pre-earnings)
• S&P 500 average forward P/E: ~22x

At 27x, you’re paying a modest premium for a company that is still growing ARR at double digits, generating positive free cash flow, and leading its category. That’s a very different risk/reward than the 45x+ it commanded two days ago.

The Honest Bear Case

Losing key salespeople is an execution risk, not a market risk. That’s both the good news and the bad news:

• Good: it’s fixable. Sales hiring and rebuilding pipeline takes 2–3 quarters, not years.
• Bad: it means the growth deceleration is self-inflicted. Management guided conservatively because they know the pipeline is thin right now.

If ARR growth settles at 16–17% and doesn’t re-accelerate, 27x is still expensive for a company growing at that rate. The overreaction thesis only works if the guide is sandbagging and the business bounces back toward 20%+.

The Setup from Here

This is the second major selloff in two quarters (Q2 was also a 16% drop on billings concerns). The pattern is: beat the quarter, fail the guide, get destroyed. At some point that pattern either confirms structural deceleration or creates a bottom.

At ~$136 with 27x forward P/E and a still-intact zero trust thesis, this is worth watching closely. Not a chase — but potentially a LEAP setup if the guide proves conservative over the next two quarters.

Key levels to watch:

• $120–$130: flush zone, potential LEAP entry if thesis holds
• Q4 ARR and billings: the only metrics that matter now
• Sales headcount recovery: watch for any management commentary on rebuilding the sales org

Key Stats

• Q3 Revenue: $850.5M — beat
• YoY Revenue Growth: +25%
• ARR: $3.525B (+25% YoY)
• FCF: $136M
• Stock reaction: −32%
• Current price: ~$136
• 52-week high: $336.99
• Forward P/E: ~27x
• ARR guidance: 16–17% growth (was 25%)
• Catalyst for drop: sales team losses, conservative guide